Physician profile
Marc D Posner
NPI 1871569574
$55,186.87
in general payments reported to CMS, 2019-2025
6 companies · $397 in 2025
The $397 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $12K · 2021: $4,280 · 2022: $7,395 · 2023: $9,061 · 2024: $2,519 · 2025: $397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,875 · Food and Beverage: $2,141 · Travel and Lodging: $1,960.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,875.00 |
| Food and Beverage | $2,141.05 |
| Travel and Lodging | $1,959.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elekta, INC. | $26,504.12 | 2019-2025 | Elekta Medical Linear Accelerator, Mosaiq |
| Bayer Healthcare Pharmaceuticals INC. | $24,148.68 | 2019-2020 | |
| Canon Medical Systems USA, INC. | $4,000.00 | 2020 | |
| Glaxosmithkline, LLC. | $483.94 | 2020-2023 | Trelegy Ellipta |
| Amgen INC. | $31.37 | 2020 | |
| Seagen INC. | $18.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Posner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.